Weak handgrip may warn of cognitive impairment

  • A large study finds weaker handgrip strength is associated with a progressively greater risk of developing severe cognitive impairment.
  • Another large long-running study similarly finds slow walking speeds and weak grip strength is associated with a greater risk of developing Alzheimer's disease.
  • Weaker grip strength, in those older than 65, was also linked to a higher risk of stroke.

A large study, involving nearly 14,000 older adults (50+) participating in the 2006 Health and Retirement Study, found that weaker handgrip strength was associated with a greater risk of developing cognitive impairment, especially severe impairment, over the eight-year study period.

Moreover, there was a dose-response type relationship, with every 5-kilogram (11-pound) reduction in handgrip strength being associated with a 10% greater risk of cognitive impairment and an 18% greater risk of severe cognitive impairment.

Handgrip strength was assessed with a hand-held dynamometer, and cognitive function with a modified Mini-Mental State Examination.

It’s suggested that reduced grip strength is associated with neural degeneration, but that maintaining your physical strength will protect you.

Data from the very long-running Framingham Heart Study also found that those who had slow walking speeds and weak grip strength had a significantly greater risk of developing Alzheimer’s disease in the next 11 years. Additionally, those older than 65 years had a higher risk of stroke if their hand grip strength was weak.

Participants were aged 35-84. Walking speed was assessed by walking a certain distance as fast as they could without running.

Reference: 

McGrath, R., Robinson-Lane, S. G., Cook, S., Clark, B. C., Herrmann, S., O’Connor, M. L., & Hackney, K. J. (2019). Handgrip Strength Is Associated with Poorer Cognitive Functioning in Aging Americans. Journal of Alzheimer’s Disease, 70(4), 1187–1196. https://doi.org/10.3233/JAD-190042

Related News

Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease, but a new study shows that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women with diabetes.

A mouse study has found that introduction of oral bacteria into the bloodstream increased risk factors for atherosclerotic heart disease, including cholesterol and inflammation, suggesting that the same bacteria that cause gum disease also promotes heart disease.

A large study, involving 3,690 older adults, has found that drugs with strong anticholinergic effects cause memory and cognitive impairment when taken continuously for a mere two months.

A new study adds to growing evidence of a link between sleep problems and Alzheimer’s. The interesting thing is that this association – between sleep apnea and Alzheimer’s biomarkers — wasn’t revealed until the data was separated out according to BMI.

Family caregivers of dementia sufferers who are reluctant to use adult day care services might like to note the findings of a telephone survey. The study involved eight daily telephone interviews on consecutive days with 173 family caregivers who use an ADS on some days.

Last year, a cancer drug, Bexarotene, was touted as a potential treatment for Alzheimer’s disease. However, four independent studies have now failed to replicate the most dramatic result of the original study: a claim that the drug could clear half the amyloid plaques in a mere 72 hours.

I’ve been happily generous with cinnamon on my breakfast ever since the first hints came out that cinnamon might help protect against Alzheimer’s (it’s not like it’s an ordeal to add cinnamon!). Now a new study has revealed why.

Late-life depression is associated with an increased risk for all-cause dementia, Alzheimer’s disease, and, most predominantly,

Because long-term cognitive decline can occur in some older adults after undergoing surgery, there has been some concern that exposure to anesthesia may be associated with increased dementia risk.

Most of the (few) approved Alzheimer’s drugs are

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news